0
Medical News & Perspectives |

Dietary Supplement Linked to Cases of Acute Hepatitis

Bridget M. Kuehn, MSJ
JAMA. 2013;310(17):1784. doi:10.1001/jama.2013.281868.
Text Size: A A A
Published online

Extract

A dietary supplement marketed as a weight loss and bodybuilding aid has been linked to dozens of cases of acute hepatitis and at least 1 death in Hawaii, according to national and state public health authorities.

News of a cluster of nonviral hepatitis cases in Hawaii broke September 26, when the state’s health department alerted residents of cases of liver inflammation and liver failure linked to use of dietary supplements for weight loss or bodybuilding. By October 8, both the US Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) had issued alerts linking the cases to a product called OxyElite Pro, which is sold nationwide by a Texas-based manufacturer. All 3 agencies were warning individuals to avoid using this supplement until further information is available.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Drug-induced liver injury. Mayo Clin Proc 2014;89(1):95-106.
Jobs
brightcove.createExperiences();